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Abstract
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia in all
ages worldwide, and with ever-increasing antibiotic resistance, the understanding of its
pathogenesis and spread is as important as ever. Recently, we reported the presence of a
Low Molecular Weight Tyrosine Phosphatase (LMWPTP) Spd1837 in the pneumococcus.
This protein is encoded in an operon, OM001 with two other genes, with previous work impli-
cating this operon as important for pneumococcal virulence. Thus, we set out to investigate
the role of the individual genes in the operon during pneumococcal pathogenesis. As
LMWPTPs play a major role in capsular polysaccharide (CPS) biosynthesis in many bacte-
ria, we tested the effect of mutating spd1837 and its adjacent genes, spd1836 and spd1838
on CPS levels. Our results suggest that individual deletion of the genes, including the
LMWPTP, did not modulate CPS levels, in multiple conditions, and in different strain back-
grounds. Following in vivo studies, Spd1836 was identified as a novel virulence factor during
pneumococcal invasive disease, in both the lungs and blood, with this protein alone respon-
sible for the effects of operon’s role in virulence. We also showed that a deletion in spd1836,
spd1838 or the overall OM001 operon reduced survival in human saliva during the condi-
tions that mimic transmission compared to the wildtype strain. With studies suggesting that
survival in human saliva may be important for transmission, this study identifies Spd1836
and Spd1838 as transmission factors, potentially facilitating the spread of the pneumococ-
cus from person to person. Overall, this study hopes to further our understanding of the bac-
terial transmission that precedes disease and outbreaks.
Introduction
Streptococcus pneumoniae (the pneumococcus) predominantly colonizes the nasopharynx as a
commensal in healthy individuals [1]. However, the bacteria can transition to be an
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opportunistic pathogen, leading to diseases with significant morbidity and mortality such as
pneumonia, bacteremia and meningitis. By blocking the colonization or carrier state with
widespread immunization, rates of transmission within the community for the strains that are
included in the vaccine formulations have declined and this in turns provides herd immunity
for the unvaccinated populations [2, 3]. These epidemiological studies have also shown that
older populations mainly acquire the pneumococcus from colonized children [4]. Therefore,
this suggests that the vaccine exerts its efficacy by limiting the spread between immunized
individuals and it is possible to target a specific step in pneumococcal pathogenesis which is
the colonization stage.
Much of our work has previously focused on determining the role that tyrosine phosphory-
lation plays in the virulence of S. pneumoniae [5–8]. We have recently characterized Spd1837
as a protein tyrosine phosphatase (PTP) of the Low Molecular Weight Protein Tyrosine Phos-
phatase family (LMWPTP) that may interact with proteins associated with pneumococcal
metabolism (Ahmad et. al., submitted for publication). LMWPTPs are also widely established
to play a role in regulating capsular polysaccharide (CPS) and exopolysaccharide (EPS) biosyn-
thesis [9].
In the chromosome of the serotype 2 S. pneumoniae strain D39, spd1837 is co-transcribed
together in the OM001 operon with the upstream translocase subunit YajC (Spd1838), and a
downstream hypothetical protein (Spd1836) (S1 Fig). While the operon is conserved across
approximately 90% of pneumococcal strains with available genome sequence, little is known
concerning the function of Spd1836 and Spd1838. Spd1836 consists of one conserved motif,
the Membrane Occupation and Recognition Nexus (MORN) repeats. Despite being found in
all domains of life and some viruses, very little is known about the MORN motif function.
Based on limited studies conducted in apicomplexan parasites and Arabidopsis, the MORN
motifs confer the ability of lipid binding, however, the subsequent role differs between species
from regulating cell size to cell budding [10]. On the other hand, Spd1838 homologs have only
been studied in Gram negative bacteria. In E. coli, YajC participates in Sec-dependent secretion
by forming a complex with SecDF and YidC which may associate with the SecYEG and SecA
ATPase to improve protein translocation efficiency [11]. Although the Sec-dependent pathway
has been extensively studied, the precise role of SecDF-YidC-YajC complex is largely
unknown.
Using a differential fluorescence induction (DFI) technique, the OM001 operon was previ-
ously identified to be significantly upregulated in several in vitro conditions that mimic infec-
tion. Subsequent deletion of this operon severely attenuated the ability of the pneumococcus
to cause infection in multiple in vivo infection models [12], however, the role of the individual
genes of the operon remained unknown.
In a recent study, Verhagen et. al. [13] conducted a genome-wide negative selection screen-
ing using Tn-seq and found 147 genes potentially required for the pneumococcal survival and
growth in human saliva. Of these, two out of the three genes from the OM001 operon (spd1836
and spd1837) were identified. Indirect evidence from studies in humans suggests saliva is a
possible medium for person-to-person spread [14]. Not only could live pneumococci be iso-
lated and cultured from human saliva [15], saliva culture was also found to be a more robust
and sensitive method for detecting the bacteria compared to conventional and the more inva-
sive methods of trans-nasal and trans-oral swabs [16]. Verhagen et. al [13] have shown that the
pneumococcus could survive and even grow in pure human saliva in 24 hours period. This
highlights the extreme ability of the pneumococcus to adapt to different environments, namely
the nasopharynx and potentially the oropharynx during the colonization step of pneumococcal
pathogenesis.
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Although transmission is the important first step that precedes carriage and disease (in fact
none of pneumococcal disease states facilitate contagion [17]), pneumococcal factors that fos-
ter transmission are not well characterized due to a lack of tractable models to study this pro-
cess until recently [18]. Indeed, pneumococcal disease occurrence is directly linked to the
strains circulating in carriage [19]. Transmission is thought to require close contact, such as
between individuals within the same households or day care centre [20, 21]. While it is gener-
ally accepted that the pneumococcus is a human-obligate pathogen with no known environ-
mental or animal reservoir, evidence accumulating is that the bacteria can survive outside of
human host. For instance, rehydrated pneumococci were able to infect mice after being left
desiccated for four weeks [22].
This study set out to investigate the role of the OM001 operon in CPS biosynthesis, viru-
lence and survival in human saliva. While there was a minimal role for the operon in CPS pro-
duction, we have shown that the operon is important for the ability of S. pneumoniae to cause
invasive disease and the ability to survive in human saliva. Specifically, we have identified
Spd1836 as a previously uncharacterized virulence factor, while Spd1836 and Spd1838 are
essential for the pneumococcal survival in human saliva at 25˚C, a condition to mimic how the
bacteria would survive outside of the human body during transmission. With ever-increasing
antibiotic resistance, the continued identification of factors important for the virulence and
transmission of the pneumococcus is critical to identify new targets for the development of
antimicrobials.
Materials and methods
Growth media and growth conditions
S. pneumoniae strains (listed in Table 1) were routinely grown either in Todd-Hewitt broth
with 1% Bacto yeast extract (THY) at 37˚C as indicated or on Columbia blood agar (BA) plates
supplemented with 5% (v/v) horse blood and grown at 37˚C in 5% CO2 or, for mouse chal-
lenge, in serum broth (10% heat-inactivated horse serum in nutrient broth). Where appropri-
ate, antibiotics were supplemented at the following concentrations: streptomycin at 150 μg
mL-1, kanamycin at 200 μg mL-1 and gentamycin at 10 μg mL-1.
Table 1. List of strains used.
Strain Description/antibiotic resistancea Source/reference
D39 Sm [8]
D39spd1837::janus Km (Ahmad et. al., submitted for publication)
D39Δspd1837 Sm (Ahmad et. al., submitted for publication)
D39Spd1837C8S Sm This work
D39Δspd1836 Sm This work
D39Δspd1838 Sm This work
D39ΔOM001 Sm This work
D39ΔOM001::janus Km This work
D39ΔOM001::OM001+ Sm This work
WU2 Sm This work
WU2spd1837::janus Km This work
WU2Δspd1837 Sm This work
a Sm, Streptomycin; Km, Kanamycin
https://doi.org/10.1371/journal.pone.0190402.t001
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Construction of chromosomal mutation in S. pneumoniae D39
Markerless, non-polar mutant strains were constructed in a serotype 2 D39 streptomycin resis-
tant strain and serotype 3 WU2 streptomycin resistant strain essentially as previously
described [8]. First, the Janus cassette was used to target and replace the spd1837 operon region
in D39 and WU2 background strains [23]. Then the D39spd1837::janus strain was transformed
with PCR products containing the in-frame deletion or point mutation in spd1837, or deletion
in spd1836, spd1838 or OM001. Additionally, PCR products containing the in-frame deletion
of spd1837was also transformed into WU2spd1837::janus strain. All oligonucleotides used are
listed in S1 Table. Transformations were carried out as described previously [24]. To create the
OM001 complemented strain, firstly, the 2 kb region upstream of the deleted OM001 operon
was amplified using the primers ZA3 and ZA16 and the 2 kb region downstream of the deleted
OM001 operon was amplified using the primers ZA4 and ZA19. These two PCR products and
the amplified Janus cassette were combined and amplified again using just the primers ZA3
and ZA4. The approximately 2.4 kb PCR product was then used to transform D39ΔOM001.
The transformants were selected on kanamycin plates, resulted in the intermediate strain,
D39ΔOM001::janus. Next, the OM001 operon region including 1 kb of flanking genomic DNA
from D39 was amplified using the primers ZA36 and ZA37. This product was then used to
transform D39ΔOM001::janus to replace the Janus cassette with the wild type copy of the
OM001 operon. The successful transformants were selected on streptomycin plate and one of
them was sequenced and verified to have acquired the OM001 operon back and this strain is
called D39ΔOM001::OM001+.
The production of polyclonal antibodies against Spd1837
Antibodies were raised against Spd1837 (purified protein > 95% pure as determined by Coo-
massie-stained SDS-PAGE (Ahmad et. al., submitted for publication)) (Institute of Medical
and Veterinary Science, Veterinary Services (Gilles Plain, SA, Australia)) in rabbits. The anti-
serum was produced under the National Health and Medical Research Council (NHMRC)
Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and was
approved by the University of Adelaide Animal Ethics Committee. The crude antibodies were
enriched and affinity-purified using purified Spd1837 before being stored at -20˚C in 50% (v/
v) glycerol [25].
SDS-PAGE and Western immunoblotting
The whole cell bacterial lysates were prepared from cultures grown in THY to an OD600nm of
approximately 0.3 and then subjected to SDS-PAGE and Western immunoblotting as
described previously [26]. The concentrations of primary antibodies used were as follows;
mouse anti-phosphotyrosine 4G10 antibodies (Bio X Cell) and mouse anti-CbpA at 1/5000
dilution, and rabbit anti-CpsD, rabbit anti-CpsB and rabbit anti-Spd1837 at 1/500 [27].
Uronic acid assay
CPS was prepared from the indicated strains grown either aerobically (BA at 37˚C with 5%
CO2) or anaerobically (BA at 37˚C with 5% CO2 in a BD GasPak™ Anaerobic Jar (Becton,
Dickinson and Company)). The uronic acid assay was performed as described previously [7,
26]. Levels were related back to a standard curve of D-glucuronic acid (Sigma Aldrich). Differ-
ences in CPS levels were analyzed by one-way analysis of variance (ANOVA) with Dunnett’s
post-hoc test.
S. pneumoniae OM001 operon
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Mouse infection model
This study was carried out in strict accordance with the recommendations in the Australian
Code of Practice for the Care and Use of Animals for Scientific Purposes (7th Edition (2004)
and 8th Edition (2013)) and the South Australian Animal Welfare Act 1985. The protocol was
approved by the Animal Ethics Committee at The University of Adelaide (approval number S/
2013/053). Outbred 5-to-6-week-old female CD1 (Swiss) mice were used in all animal experi-
ments. For intranasal (i.n.) challenge, mice were anesthetized by intraperitoneal (i.p.) injection
of pentobarbital sodium (Nembutal; Rhone-Merieux) at a dose of 66 μg per g of body weight,
followed by i.n. challenge with 50 μL of bacterial suspension containing approximately 1×107
CFU mL-1 bacteria in serum broth. The challenge dose was confirmed retrospectively by serial
dilution and plating on BA. Mice were euthanized by CO2 asphyxiation at the 48 hr post-chal-
lenge. Blood was collected by syringe from the posterior vena cava. The pleural cavity was
lavaged with 1 mL sterile PBS containing 2 mM EDTA introduced through the diaphragm.
Pulmonary vasculature was perfused by infusion of sterile PBS through the heart. Lungs were
subsequently excised into 2-mL vials containing 1 mL sterile PBS and 2.8-mm-diameter
ceramic beads for CFU counts. To obtain unattached pneumococci, the nasopharynx was sub-
jected to lavage by insertion of a 26-gauge needle sheathed in tubing into the tracheal end of
the upper respiratory tract and injection of 1 mL 0.5% trypsin–1×PBS through the nasophar-
ynx. Additionally, the upper palate and nasopharynx were excised and placed into 2-mL vials
containing 1 mL sterile PBS and 2.8-mm-diameter ceramic beads to obtain attached pneumo-
cocci. CFU counts for both the nasal wash and nasal tissue samples were combined to deter-
mine the total number of bacteria in the nasopharynx. Lung and nasopharyngeal tissues were
homogenized using a Precellys 24 tissue homogenizer (Bertin Technologies) at 3 cycles of 30 s
and 5,000 rpm. 40 μL aliquots of lung homogenate, nasopharyngeal tissues homogenate and
pleural lavage, and 20 μL aliquots of blood were serially diluted and plated on BA supple-
mented with gentamycin to determine the number of CFU in these niches. Data were analyzed
using non-parametric Mann-Whitney test. The incidence of pneumococcal invasion into the
lungs and blood of mice were compared using two-tailed Fisher’s exact test.
Evaluation of the survival of S. pneumoniae strains in human saliva
The University of Adelaide Human Research Ethics Committee approved the study protocol
and the written informed consent form with approval number of H-2016-224. Saliva collection
and S. pneumoniae survival tests were conducted essentially as described by Verhagen et. al.
[13] with a few modifications. The additional criteria for recruiting participants include ‘cur-
rently a non-smoker’ and ‘no respiratory or periodontal disease or infection’ as smokers and
individuals with such disease or infection were shown previously to have human leukocyte
elastase in their saliva and therefore is not representative of general, healthy population [28,
29]. Briefly, fasting saliva of the donors was pooled and centrifuged at 16,000 g at 4˚C for 15
minutes. The supernatant was sterilized by ultrafiltration with 0.45 μm Minisart filters (Sarto-
rius Stedim Biotech). Before inoculation in saliva, the strains were grown in THY for 2 hr,
diluted to a starting concentration of 1 × 106 CFU mL-1 and washed twice in sterile PBS. The
bacteria was incubated with at least 500 μL saliva at two conditions: 37˚C with 5% CO2 (repre-
senting in-host carriage) and 25˚C without CO2 (representing transmission). At t = 0, t = 3,
t = 22, and t = 24 hr, samples were taken for CFU count. The number of bacteria at specific
time point was enumerated by plating serial dilutions on BA plates. Experiments were per-
formed in duplicates and repeated three times independently. Statistical differences between
survival of S. pneumoniae in multiple dilutions of saliva were assessed by a one-way ANOVA
and Dunnett’s post hoc tests.
S. pneumoniae OM001 operon
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Results
The proteins encoded in OM001 operon do not play a role in CPS
regulation
In another study, we showed that the Spd1837 was a PTP from the LMWPTP family (Ahmad
et. al., submitted for publication). As a number of LMWPTPs modulate CPS and EPS biosyn-
thesis, we investigated if Spd1837 and the co-transcribed genes encoding Spd1836 and
Spd1838 played a role in the regulation of CPS in S. pneumoniae. Separate non-polar marker-
less deletion mutations in spd1836, spd1837, spd1838 and of all three genes of the OM001
operon were constructed in the chromosome of D39. We also constructed an in-frame
unmarked point mutant (D39Spd1837C8S) which would not have any phosphatase activity.
The strains (D39Δspd1837, D39Spd1837C8S, D39Δspd1838, D39Δspd1836 and D39ΔOM001)
showed similar growth profiles to the parental strain D39 (S2 Fig).
Western immunoblot analysis with an antibody against Spd1837, showed that
D39Δspd1837 and D39ΔOM001 did not produce Spd1837 while D39Spd1837C8S still had the
mutant form of Spd1837 produced at a level equivalent to the wildtype, as did D39Δspd1838
and D39Δspd1836 (Fig 1A). As tyrosine phosphorylation of CpsD is important for the CPS
Fig 1. Proteins encoded by OM001 operon do not alter tyrosine phosphorylation of CpsD. Proteins from whole-
cell lysates from D39, D39Δspd1837, D39Spd1837C8S, D39Δspd1838, D39Δspd1836 and D39ΔOM001 cells were
separated by SDS-PAGE, and Western immunoblotting was undertaken with anti-Spd1837 (A), anti-CpsD (B), anti-
phosphotyrosine (PY) (C), anti-CpsB (D) and anti-CbpA (E). MW, molecular weight (in kDa). The arrow on (C)
indicates a band corresponds to CpsD.
https://doi.org/10.1371/journal.pone.0190402.g001
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regulation in the pneumococcus [30, 31], we analyzed the overall tyrosine phosphorylation
profiles of the mutant strains. All six strains had similar levels of overall tyrosine phosphoryla-
tion, specifically of CpsD (Fig 1B and 1C), indicating that at least under the growth condition
used, Spd1836, Spd1837 and Spd1838 had no detectable effect on protein tyrosine phosphory-
lation. Additionally, the expression of the other known PTP in the pneumococcus, CpsB was
also similar in these strains (Fig 1D). As a loading control, the expression of the choline-bind-
ing protein A (CbpA) was also checked and this verified that similar amount of proteins were
loaded into each lane (Fig 1E).
We then investigated whether these mutations modulated the synthesis of the CPS, using
the uronic acid assay as described in the Materials and Methods. There was no significant dif-
ference in the amount of both total and cell wall-associated CPS produced by D39,
D39Δspd1837, D39Spd1837C8S, D39Δspd1838 and D39Δspd1836while the operon deletion
mutant, D39ΔOM001 had a slightly higher cell wall-associated CPS compared to that of the
wildtype D39 strain under aerobic condition (Fig 2A). When we investigated CPS biosynthesis
in anaerobic conditions, the overall total and cell wall-associated CPS levels of all strains were
increased by approximately 20%, as previously observed [32]. However, there was no signifi-
cant effect of mutating spd1836, spd1837 or spd1838 individually or together either on total or
cell wall-associated CPS synthesis (Fig 2B).
Serotype 3 strains produce CPS via synthase-dependent mechanism [33], compared to the
Wzy-dependent mechanism in serotype 2 and all other strains except serotype 37 [34–36].
This implies that Spd1837 is the only identified PTP in this serotype as it does not possess
CpsB [33]. Thus, in order to investigate if Spd1837 played a role in CPS biosynthesis in this
background, we also constructed a spd1837 deletion in the serotype 3 strain WU2. Similar to
in D39, there was no significant difference in CPS levels between WU2 and WU2Δspd1837,
either when the bacteria were grown aerobically (Fig 2C) or anaerobically (Fig 2D). This sug-
gests that Spd1837 plays no role in the regulation of CPS biosynthesis in two serotypes of S.
pneumoniae that synthesize CPS via two different mechanisms.
Contribution of Spd1836, Spd1837 and Spd1838 to virulence in mouse
model of infection
Previous work has shown that the OM001 operon encoding spd1836, spd1837 and spd1838
plays a role in pneumococcal virulence [12]. We then undertook animal experiments to inves-
tigate the contribution of the individual genes of the operon to virulence in mice using an
intranasal model. We found that none of the groups challenged with D39Δspd1837,
D39Spd1837C8S, D39Δspd1838, D39Δspd1836 and D39ΔOM001 showed statistically reduced
number of bacteria recovered from the nasopharynx, pleural lavage and lungs compared to the
group challenged with the wildtype D39 (Fig 3A and 3B). There was however a significant
reduction in the number of pneumococci recovered in the blood of mice challenged with
D39Δspd1836 compared to the wildtype D39 (Fig 3C). Although not reaching statistical signifi-
cance, a similar trend towards reduced number of bacteria recovered from the nasopharynx,
pleural lavage, and lungs was observed for the group challenged with D39Δspd1836 and
D39ΔOM001, and D39ΔOM001 from the blood compared to the group challenged with the
wildtype D39 (Fig 3). Therefore, invasion of the lungs and blood was also compared by Fisher’s
exact test. Using this test, we found that significantly fewer mice succumbed with invasive dis-
ease of lungs and blood when challenged with D39Δspd1836 and D39ΔOM001 compared to
the wildtype D39. Eight out of fifteen mice challenged with D39Δspd1836 and three out of
eight mice challenged with D39ΔOM001 had negligible number of pneumococci recovered
from their lungs and blood while only one out of sixteen mice challenged with the wildtype
S. pneumoniae OM001 operon
PLOS ONE | https://doi.org/10.1371/journal.pone.0190402 January 2, 2018 7 / 15
D39 did not succumb to invasive disease. Thus, this showed that the contribution of OM001
operon to pneumococcal virulence was solely due to spd1836.
Spd1836 and Spd1838 may be essential for pneumococcal survival in
human saliva
As previous work by Verhagen et. al. [13] had suggested that the OM001 operon may play a
role in the survival in human saliva, we investigated if our defined spd1836, spd1837 and
Fig 2. CPS production by D39 and WU2 strains. CPS was prepared from equal numbers of bacterial cells of D39, D39Δspd1837, D39Spd1837C8S, D39Δspd1838,
D39Δspd1836, and D39ΔOM001 grown either aerobically (A) or anaerobically (B) and WU2 and WU2Δspd1837 grown either aerobically (C) or grown
anaerobically (D). The CPS level was determined by uronic acid assay as described in Materials and Methods. The white bars represent the total CPS produced by
various mutants as a percentage of total D39 CPS ((A) and (B)) or total WU2 CPS ((C) and (D)). The black bars represent the cell wall-associated CPS produced by
mutants as a percentage of total D39 CPS ((A) and (B)) or total WU2 CPS ((B) and (C)). Bars represent means from three independent replicates while the error
bars represent the standard error.
https://doi.org/10.1371/journal.pone.0190402.g002
S. pneumoniae OM001 operon
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spd1838mutants showed less survival in saliva compared to the wildtype D39 strain. Deletion
of spd1836, spd1838 and the overall deletion of the operon OM001 resulted in lower bacterial
survival when grown in human saliva at 25˚C without CO2 compared to the wildtype D39, and
complementation of OM001 into D39ΔOM001 restored the survival percentage to wildtype
level (Fig 4A). In contrast, none of the mutants including the complemented strain showed sig-
nificant differences in survival when incubated in human saliva at 37˚C with CO2 compared to
the wildtype strain (Fig 4B). Notably, neither chromosomal deletion nor the active site point
mutation of spd1837 (spd1837C8S) affected pneumococcal survival at 25˚C without CO2 and at
37˚C with CO2 (Fig 4A and 4B). Overall, the results suggest that deletion in spd1836 and
spd1838 reduced pneumococcal survival in human saliva during conditions that mimic
Fig 3. Infection of mice with D39 bacteria and their mutant derivatives. Mice were challenged with D39, D39Δspd1837, D39Spd1837C8S, D39Δspd1838,
D39Δspd1836 and D39ΔOM001. Bacteria were enumerated from the nasopharynx and pleural lavage (A), lungs (B) and blood (C) of each mouse at 48 h post-
infection (n = at least 5 per group). Horizontal line represents geometric mean; horizontal broken line denotes limit of detection abbreviated as LD (250 CFU
for (A), 100 CFU for (B) and 50 CFU for (C)). , P< 0.05; Statistical significance was calculated on log-transformed data using Mann Whitney tests. The
incidence of pneumococcal invasion into the lungs and blood of mice were compared using two-tailed Fisher’s exact test.
https://doi.org/10.1371/journal.pone.0190402.g003
S. pneumoniae OM001 operon
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transmission (at 25˚C without CO2), but not during conditions that mimic in-host carriage
(37˚C with CO2). With evidence that human saliva can be a potential reservoir for the person
to person spread of the pneumococcus, this would identify these factors as novel factors poten-
tially important for pneumococcal transmission.
Discussion
While the OM001 is highly conserved amongst pneumococcal strains, little is known concern-
ing the roles that the individual genes play in the physiology and virulence of the pneumococ-
cus. Previously we have shown that Spd1837 is a PTP of the LMWPTP family (Ahmad et. al.,
submitted for publication), and as data suggested importance of the operon in virulence [12],
we investigated the individual characteristics of the mutants of these three genes in the operon.
Protein tyrosine phosphorylation in bacteria is now recognized as a critical post-transla-
tional regulation of virulence, modulating the pathogenic ability of a range of important
human pathogens [9, 37]. The pneumococcus is one of the pathogens for which tyrosine phos-
phorylation plays an important role, regulating the biosynthesis of its single most important
virulence factor, the CPS. The PTP CpsB, has been shown to be required for complete pneu-
mococcal encapsulation [7]. Therefore, we investigated if the LMWPTP Spd1837 and its
Fig 4. Survival of D39 bacteria and mutant derivatives in human saliva. A starting concentration of 106 CFU mL-1 wildtype or mutant bacteria were incubated
with saliva at the two conditions; (A) at 25˚C without CO2 and (B) at 37˚C with CO2. Experiments were performed in duplicate and repeated three times,
independently. There was an approximately 0.5-log decrease in viable count for the D39 strain grown at 25˚C without CO2 and approximately 2-log decrease in
viable count for the D39 strain grown at 37˚C with CO2. The CFU for D39 at t = 24 at 25˚C without CO2 was 5 × 105 and the CFU for D39 at t = 24 at 37˚C with
CO2 was 1 × 104. Data were normalized such that the values represent the survival percentage of the mutant strains relative to the wildtype D39 (taken as 100%) ±
SEM. Statistical differences between survival of S. pneumoniae in multiple dilutions of saliva were assessed by one-way ANOVA and Dunnett’s post hoc tests. ,
P< 0.01, , P< 0.001.
https://doi.org/10.1371/journal.pone.0190402.g004
S. pneumoniae OM001 operon
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adjacent co-transcribed proteins, Spd1836 and Spd1838 play a role in the biosynthesis of CPS
in the pneumococcus. However, neither Spd1837 nor Spd1836 and Spd1838 modulated tyro-
sine phosphorylation or CPS production under either aerobic or anaerobic conditions unlike
CpsB [38], although the cumulative effects of deleting spd1836, spd1837 and spd1838 resulted
in a slight increase in the levels of cell wall-associated CPS compared to the wildtype. This is
perhaps unsurprising for the LMWPTP Spd1837 as PTPs not co-transcribed with bacterial
tyrosine kinases generally have species specific roles (S3 and S4 Tables).
As a deletion mutation in the OM001 operon was previously reported to attenuate pneumo-
coccal virulence in multiple in vivo models of infection [12], we investigated the individual
contributions of spd1836, spd1837, and spd1838 to pneumococcal virulence. Similar to the pre-
vious study, we found that the deletion of the operon OM001 led to a reduction in in vivo viru-
lence with fewer mice succumbing to invasive disease of the lungs and blood. However, our
data suggested that it was spd1836 absence rather than the combination of spd1836, spd1837
and spd1838 deletion that led to the reduced invasive capacity of the pneumococcus, with the
D39Δspd1836mutant showing similar results as the D39ΔOM001 mutant. Our decrease in vir-
ulence were not as dramatic an attenuation as seen with the deletion of the operon OM001 pre-
viously [12], however, the prior study utilized different models including gerbils. Regardless,
our study identified Spd1836 as a novel virulence factor, playing a role in invasive disease of
lungs and blood.
Based on Tn-seq conducted by Verhagen and colleagues [13], the spd1836 and spd1837
genes (locus tag SP195_1980 and SP195_1981 respectively in the previous study) were impli-
cated as being potentially important for pneumococcal transmission, however, no testing of
individual mutants was reported. Here, we have shown that Spd1836, and Spd1838 along with
the operon as a whole play a role in the survival of pneumococci in human saliva, with respec-
tive mutants showing statistically significant decreases in CFU when incubated at 25˚C with-
out CO2 but not when incubated at 37˚C with CO2. These results are slightly different to those
found by the previous study, as we did not see any difference in D39Δspd1837 and our differ-
ences were only seen in conditions which mimic transmission (25˚C without CO2). However,
our study using defined mutants (rather than the Tn-seq) in a different strain (serotype 2 D39
vs serotype 19F) allowed for a more detailed analysis of the characteristics of these mutants. It
would be interesting to investigate the precise role of Spd1838 and Spd1836 proteins in trans-
mission via saliva, given their effects on pneumococcal survival in saliva as reported here.
The epidemiological evidence following vaccine administration highlights the importance
of studying transmission and colonization which was previously overlooked in favour of viru-
lence and invasion studies. Given the recent advances in pneumococcal transmission studies
[39, 40], one can expect more factors important for transmission will be characterized in the
future. We are currently working to identify the mechanisms by which genes of this operon
modulate virulence and transmission of the pneumococcus. Additionally, Spd1836 emerges
from our study to be a previously uncharacterized virulence factor that may be important for
progression to invasive pneumococcal disease. Further work is needed to identify the mecha-
nism for this, and to identify whether this presents as a novel target for the development of
new antimicrobials.
Supporting information
S1 Fig. Schematic representation of OM001 operon. In the chromosome, the operon consists
of spd1838which encodes for a translocase, YajC (99 amino acids); spd1837 which encodes for
a low molecular weight protein tyrosine phosphatase (142 amino acids); and spd1836 which
encodes for a Membrane Occupation and Recognition Nexus (MORN) repeats-containing
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protein (136 amino acids).
(TIF)
S2 Fig. Growth profiles of D39 strains. Growth curves of S. pneumoniae strains grown in
THY. Data are mean ± SEM absorbance measurements from three independent biological
experiments.
(TIF)
S3 Fig. Viable bacterial count of the strains at different time points after incubation in
human saliva. A starting concentration of 106 CFU mL-1 of wildtype or mutant strain was
incubated with saliva at two conditions, at 25˚C without CO2 (A) and at 37˚C with CO2 (B).
Samples were taken for CFU count at t = 0 and 3 hr. Data are mean ± SEM from three inde-
pendent biological experiments.
(TIF)
S1 Table. List of oligonucleotides used. Sequence of oligonucleotides were derived from the
chromosomal DNA sequence of S. pneumoniae serotype 2 D39 and serotype 3 WU2.
(PDF)
S2 Table. The total number of mice and the number of surviving mice at the end of an
intranasal challenge experiment with the strains.
(PDF)
S3 Table. LMWPTP-bacterial tyrosine kinase (BY-kinase) pair with a role in capsular poly-
saccharide (CPS)/exopolysaccharide (EPS) biosynthesis.
(PDF)
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